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Examination of a profile of data already existing on 1,3-butadiene shows adequate knowledge in many
areas of toxicology that are conventionally required in hazard identification. However, while much
progress has been madein areasofmetabolism and pharmacokinetics, further studieswould be worthwhile
to improve mechanistic understanding such as the examination of alternate metabolic pathways, the
generation ofinterspecies scalingfactors, andan assessmentoftherelevance ofvarious tumorsites. In this
respect, data pertaining to repeated and pulse exposures of rodents and primates would be helpful.
Another important aspect is the need to understand any human health implications of the observed
1,3-butadiene-induction of the murine leukemia virus. In this respect, studies have been pursued that
include the comparison of leukemogenesis in congenetic strains, the leukemogenicity ofviral isolates in
rodent carcinogenicity and human cell culture studies, and the mechanisms of activation of ecotropic
proviral sequences.
Molecular epidemiological and toxicological research is ongoing in rodents and primates to evaluate
hemoglobin adduct formation as an index of 1,3-butadiene exposure. Challenges ofspecificity, sensitivity,
and simplification of current procedures need to be overcome.
Recent mutagenicity and metabolism data suggest that structurally-related isoprene may have carcino-
genic potential. The use ofinterstrain comparative studies anddata in asecond species is discussed, as well
as proposed metabolism studies.
Review of 1,3-Butadiene Toxicity
In discussing future research directions for 1,3-bu-
tadiene it is appropriate to briefly review the current
statusoftoxicityinformation on 1,3-butadiene. Existing
animaltoxicity datafor 1,3-butadiene can be arrayed as
atoxicologicalprofileintheformatthathasbeenutilized
bythe Agency forToxic Substances and Disease Regis-
tryforotherchemicals (Fig. 1). Fromthis, itisapparent
that adequate data exist for these conventional toxicity
fields (acute, chronic etc.) to characterize toxic poten-
tial, particularly bythe inhalation route. There are data
in other fields too. With respect to mutagenicity, until
recently 1,3-butadienepersehadonlybeentested inthe
Salmonella/Ames assay (1). Now, in vivo genotoxicity
data has been generated by Tice et al. (2) and Cun-
ninghametal(3). Thelatterauthorsshowaninteresting
species difference in the incidence of sister chromatid
exchanges and of micronuclei occurring in the bone
marrowofthemousebutnotoftherat. Sisterchromatid
exchange in the peripheral blood of 1,3-butadiene-
exposed primates is being evaluated. Finally, immu-
notoxicity has been adequately studied byThurmond et
al. (4) with overall no immunological effect seen.
Possible Research Areas
Three areas for possible research are a) metabolism
and pharmacokinetic studies (repeated and pulse ex-
posure in rodents and primates); b) mechanisms of mu-
rine leukemogenesis (rodent carcinogenicity and human
cellculturestudies), c)hemoglobinadductformation as a
means of biological monitoring. Each of these areas is
now discussed in turn.
Metabolism and Pharmacokinetic Studies
Bolt et al. (5) and Kreiling et al. (6) have shown that
1,3-butadiene is metabolized to 1,2-epoxy-3-butene both
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FIGURE 1. Adequacy of the data base on health effects of 1,3-buta-
diene.M. G. BIRD
in vitro and in vivo. Bond et al. (7) have confirmed and
extended these observations by demonstrating that the
mutagenic 1,2-epoxy-3-butene and diepoxybutane are
present in the blood as metabolites of1,3-butadiene and
that these epoxides have been detected at two to five
times greater concentrations in the blood ofmice than of
rats (8).
The species differences and variety of carcinogenic
and hematological responses indicated in the rodent
carcinogenicity studies of 1,3-butadiene (9,10) cast
doubt on the omnipotent role presently attributed to
these epoxides and allows for the presence and toxic
significance of other metabolites. In addition, obser-
vations by Anderson et al. (11) show a lowering of
hepatic nonprotein sulfhydryl levels following the IP
injection of 1,2-epoxy-3-butene, and suggest that the
epoxide had been further metabolized. Glutathione
S-transferase may play an important role in a toxifica-
tion or a detoxification pathway for 1,3-butadiene meta-
bolism in the primate (Fig. 2). Further comparative
species studies of the rate and extent of glutathione
conjugation and of epoxide hydrolase activity would be
beneficial in that they might supply further reason for
the species differences in sensitivity or tissue suscepti-
bility.
One possibility that might explain some of the acute
hematological effects seen with 1,3-butadiene is the
hypothesis that 1,3-butadiene can be metabolized in the
mouse to the homologous 4-carbon dialdehyde, namely
butenedial (12). In a joint collaborative project with
Surrey University (UK) and the Robert Wood Johnson
Medical School in New Jersey, computer graphics and
electronic structure calculations (Tables 1 and 2) were
used to determine that butenedial is likely to share
similar lipophilicity and toxic properties as ofthe 6-car-
bon dialdehyde, muconaldehyde. Muconaldehyde has
been shown to produce hematotoxicity (13).
Although it is now known that 1,3-butadiene does not
induce its own metabolism (15), further pharmacoki-
neticsandmetabolismstudiesusingpulse exposures and
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FIGURE 2. Potential pathway for the formation ofbutenedialdehyde.
also repeated exposures, rather than single (6-hr) ones,
may contribute to our mechanistic understanding of
1,3-butadiene toxicity. Itispossiblethatsuch exposures
may affect a quantitatively minor metabolic pathway,
which has majortoxicological ramifications. These stud-
ies may elucidate why exposure concentration is a more
important determinant in thymic lymphoma/leukemia
formation than the duration of exposure. The data could
also be used in developing scaling factors essential for
interspecies extrapolation of risk assessment. Inter-
species disposition studies involving DNA adduct de-
terminations intargettissues mayprovide answers asto
the reason forthe wide range oftumor sites observed in
the mouse compared to those in the rat.
Mechanisms of Murine Leukemogenesis
The studies of Irons and coworkers (16,17) show that
the endogenous retrovirus (MuLV) may play a role in
1,3-butadiene-induced T-cell lymphoma. A marked dif-
ference was found between the incidence ofthymic lym-
phomaAleukemia in the B6C3F1 mouse (57%) exposed to
1,3-butadiene for 1 year and the incidence in the simi-
larly exposed NIH Swiss mouse (14%), a strain in which
the MuLV proviral sequences are incomplete. As a
future research direction, Irons has suggested that the
Table 1. MINDO/3 optimized molecular dimensions for dialdehydes.a
Compound Length, A Width, A Depth, A Area/depth Area/depth2 Length/width
Muconaldehyde 10.3 5.5 4.9 11.6 2.4 1.9
Butenedialdehyde 8.1 5.5 3.3 13.5 4.1 1.5
aCalculated by MINDO/3 method of Bingham et al. (14).
Table 2. Electronic parameters for dialdehydes.a
Compound E (HOMO)b E (LEMO)b AEC SEd Q¶If
units eV eV eV electrons/eV e D
Muconaldehyde - 9.85 -0.52 9.33 2.68 2.74 0.00
Butenedialdehyde - 10.04 -0.47 9.57 2.01 2.44 0.00
aCalculated by MINDO/3 method ofBingham et al. (14).
bE (HOMO) and E (LEMO) are the highest occupied and lowest empty molecular orbital energies, respectively, in electron volts (eV).
CAE is the difference between E (HOMO) and E (LEMO) energies in electron volts (eO).
dSE is the electrophilic superdelocalizability summed over all the atoms in electrons per electron volt.
eQT is the net atomic charge summed over all atoms in electron units (e).
f'L is the dipole moment in Debyes (D).
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significance of the B6C3F1 mouse as a model for the
assessment of leukemia risk in man should be reex-
amined. The research he envisages would include com-
parative incidence studies on congenic mouse strains
(selected so that any difference in strain response to
1,3-butadieneexposurewouldbeattributableonlytothe
retroviral gene differences), and astudyofthe leukemic
potential of viral isolates from 1,3-butadiene-induced
tumors. Other studies would include the use ofin vitro
culture systems using both human and murine cells to
determine whether ornot 1,3-butadiene anditsmetabo-
lites can alter retroviral expression in the mouse and,
similarly, in human cells. Primate studies (with the
Simianmonkey) couldbeusedforfurtherstudyofretro-
viral interaction and of bone marrow changes. Such
studies may contribute to our understanding of the
relevance ofthe murine response for other chemicals in
addition to 1,3-butadiene.
HemoglobinCarcinogenicityandHumanCell
Culture Studies
The final area is that of adduct formation. Laib (18)
has reported the detection of a DNA adduct with
1,2-epoxy-3-butene and other uncharacterized adducts
intheblood ofmice exposed to 1,3-butadiene. NIEHSis
working on the use ofhemoglobin adducts as biological
markers ofexposure. Dahl (15) reported a dose-related
covalent binding of 1,3-butadiene to hemoglobin in the
rodentandthepresence(thoughatneardetectionlimits)
ofsimilaradductsintheprimateattheoneconcentration
of 1,3-butadiene (10 ppm in air) examined to date. The
next stage is to refine the sensitivity and specificity of
the assay and to switch from the use ofradiolabel to a
cold method.
Further research on the toxicology ofisoprene is also
needed since this chemical is structurally similar to
1,3-butadiene, and recently reported (19) micronucleus
and sister chromatic exchange studies indicate that iso-
prene has some mutagenic potential in mice. Studies by
Dahl et al. (20) and by DelMonte et al. (21) indicate that
the metabolism ofisoprene may be qualitatively similar
to that of 1,3-butadiene in terms of the formation of
equivalent mono- and diepoxides. Studies ofisoprene in
primates are being performed to characterize the meta-
bolicprofileinthatspeciesfollowinganincreasingseries
of concentrations each of 2 hr duration. Melnick et al.
(22) are using an extended 3-month toxicity study
(6-month exposure/6-month hold) to determine whether
ornotisoprene willproduce thymiclymphoma/leukemia
and other tumors in the B6C3F1 mice, which was the
case for 1,3-butadiene under a similar testing regimen.
Further metabolism studies in the B6C3F1 mouse are
also planned by the National Toxicology Program to
compliment the published work in the rat.
The International Institute ofSynthetic Rubber Pro-
ducers (IISRP) is examining the merits of a 1-year
interstrain comparative study of isoprene, similar to
that conducted by Irons (16) with 1,3-butadiene in the
NIH Swiss and B6C3Fj mouse and a two-year study of
isoprene in the Sprague-Dawley rat. These studies
would provide a comparison to 1,3-butadiene and com-
plement the possible retrovirus research proposal, de-
scribed previously for 1,3-butadiene. Industrialhygiene
data-gathering and a prospective epidemiology study
are also being considered for isoprene.
Conclusion
Ourunderstanding of1,3-butadiene, more so than for
many other compounds, has benefitted from the recent
burst of research activity on this compound. It is an-
ticipatedthatfutureresearchwilllead toabetterunder-
standingofspeciesdifferencesinmetabolismandtumor-
igenic response, which in turn should reduce current
uncertainties in risk-assessment modeling.
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